Compare RRC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RRC | BIO |
|---|---|---|
| Founded | 1976 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | RRC | BIO |
|---|---|---|
| Price | $36.34 | $296.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | $41.29 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.9M | 199.1K |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | ★ 19.84 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,891,506,000.00 | $2,557,500,000.00 |
| Revenue This Year | $27.23 | $1.62 |
| Revenue Next Year | $11.85 | $2.26 |
| P/E Ratio | $15.29 | ★ N/A |
| Revenue Growth | ★ 24.57 | N/A |
| 52 Week Low | $30.32 | $211.43 |
| 52 Week High | $43.50 | $373.69 |
| Indicator | RRC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 34.91 |
| Support Level | $35.70 | $306.52 |
| Resistance Level | $37.11 | $316.63 |
| Average True Range (ATR) | 1.12 | 10.12 |
| MACD | 0.37 | -2.04 |
| Stochastic Oscillator | 80.09 | 7.24 |
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.2 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.